(3-(Cyclopentyloxy)-4-methoxyphenyl)boronic acid, 95.0%, 250mg

APhos Pd G2, 98%, 250mg

1H-Isoindole-1,3(2H)-dione, 5-[5-[[(5Z)-3-(4-bromophenyl)-2-imino-4-oxo-5-thiazolidinylidene]methyl]-2-furanyl]-, 97%, 10mg

1-Isopropyl-1H-pyrazole-4-carbaldehyde, 95.0%, 10g

Mortars with pestle low form, 80 ml, 1 Set

1H-Pyrrolo[2,3-c]pyridine-3-carbaldehyde, 95.0%, 10g

(4,6-dimethylpyrimidin-2-yl)cyanamide, 250mg

Tert-butyl 3-(1H-pyrazol-1-yl)azetidine-1-carboxylate, 98%, 250mg

(2E)-3-(3-Aminophenyl)acrylic acid, 95.0%, 1g

4-((3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)thiomorpholine, 97%, 1g

5,6,7,8-Tetrahydroquinolin-3-amine, 95.0%, 500mg

Naltrexone Hydrochloride>98.0%(HPLC)(GC)250mg

2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one, 95.0%, 50mg